https://www.genervon.com/genervon daily 1.0 2021-04-26 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1508527174495-P2EBOTF7BX4T2SOR0WSW/AdobeStock_18133113-SQ.jpg Home https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1508527490520-NUZUDSYZJ2DSJH7CDGWQ/AdobeStock_141025938-SQ.jpg Home https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1508477936735-OF607KTH5DIEP1XZ0O79/AdobeStock_152465296-SQ.jpg Home https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1508442386399-QCT1ZMNR6W4IPQHBS1EO/AdobeStock_75313743.jpeg Home https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1508563279264-4CU72Q2IR4J3JFKXW8I5/AdobeStock_112508174.jpeg Home https://www.genervon.com/science/innovation daily 0.75 2017-10-19 https://www.genervon.com/pressreleases daily 0.75 2020-03-04 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1508740458837-GEWILZB8C1PI9E57JAMJ/AdobeStock_112508174.jpeg Press Releases (OLD) https://www.genervon.com/pressreleases/2020/3/3/genervon-to-present-gm6s-effect-in-modulating-alzheimers-disease-at-the-asent2020-annual-meeting monthly 0.5 2020-03-04 https://www.genervon.com/pressreleases/2018/9/25/genervon-presents-mechanisms-of-actions-in-alzheimers-disease-including-results-confirming-that-gm6-attenuates-alzheimers-disease-in-mouse-model-in-part-by-reducing-inflammation monthly 0.5 2018-09-25 https://www.genervon.com/pressreleases/genervon-at-bio-2018 monthly 0.5 2020-03-04 https://www.genervon.com/pressreleases/2017/12/8/gm604-is-a-multi-target-regulator-that-provides-a-novel-treatment-strategy-for-als monthly 0.5 2017-12-11 https://www.genervon.com/pressreleases/2017/10/20/i9kzz4nusvc2p12xlxlccvotx5chjm monthly 0.5 2017-10-20 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1508528855760-HXG3S4XWE29130QL6F1Y/20170508invitation.jpg Press Releases (OLD) - You are invited to our luncheon presentation - World Preclinical Congress, Translational Strategies In CNS https://www.genervon.com/pressreleases/2017/10/20/confidential-data-from-genervon-als-phase-2a-clinical-trial-were-released-and-published monthly 0.5 2017-10-28 https://www.genervon.com/pressreleases/2017/10/20/bioinformatics-report-confirms-gm6s-role-as-master-regulator monthly 0.5 2017-10-28 https://www.genervon.com/pressreleases/2017/10/20/genervon-gm604-received-eus-orphan-drug-designation-to-treat-als monthly 0.5 2017-10-24 https://www.genervon.com/pressreleases/2017/10/20/als-patients-from-around-the-world-responding-well-to-genervons-gm604 monthly 0.5 2017-10-24 https://www.genervon.com/pressreleases/2017/10/20/genervon-case-report-update-from-international-als-patients monthly 0.5 2017-10-20 https://www.genervon.com/pressreleases/2017/10/20/gm604-to-be-granted-orphan-drug-status-in-europe monthly 0.5 2017-10-20 https://www.genervon.com/pressreleases/2017/10/20/updated-summary-on-genervon-science-gm604 monthly 0.5 2017-10-20 https://www.genervon.com/pressreleases/2017/10/20/genervon-filed-patent-for-using-gm604-modulations-of-als-disease-biomarkers-showing-homeostasis-leading-to-prognosis-and-therapeutic-treatment-for-als-disease monthly 0.5 2017-10-23 https://www.genervon.com/pressreleases/2017/10/20/fda-grants-orphan-drug-designation-for-genervons-breakthrough-multi-target-als-bio-drug-gm604 monthly 0.5 2017-10-20 https://www.genervon.com/pressreleases/2017/10/20/fda-granted-fast-track-designation-for-genervons-breakthrough-biotechnology-multi-target-als-drug-gm604-expediting-drug-approval-process monthly 0.5 2017-10-20 https://www.genervon.com/pressreleases/2017/10/20/fda-approves-broadly-inclusive-phase-iia-als-clinical-trial-with-gm604-a-biotechnology-innovation monthly 0.5 2017-10-20 https://www.genervon.com/pressreleases/2017/10/20/multiple-target-als-drug-ready-for-genervons-phase-2-trial monthly 0.5 2017-10-20 https://www.genervon.com/pressreleases/2017/10/20/european-patent-office-issues-its-intention-to-grant-genervon-biopharmaceuticals-a-european-patent-on-methods-of-treating-neuronal-disorders-using-mntf-peptides-and-analogs-thereof monthly 0.5 2017-10-20 https://www.genervon.com/our-science daily 0.75 2021-04-24 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619215039525-HOAZK4WH6TDEUIVXMWLN/MNTF+expression.png Science https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619221196729-KDAAOK3AN96UYRYUZCL9/MNTF+neurotrophin.png Science https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619223020361-ISNAW7XA3OE031R1X876/GM6+development.jpg Science https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619236076190-MU0TCU0HDLG8KCY4RR8O/GM6+BBB.png Science https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619226211470-E7ZSHDNHH209S1KN4T7X/GM6+neuroprotection+2.png Science https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619236405107-D3D530VVDV8I9G5D242F/Drug+Properties.png Science https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619248952671-ZO1XP6DNEX1L37GJNNNW/pipeline+chart+-+large.png Science https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619214809361-N3IOWWV20JDMBJ3C17GT/AdobeStock_18133113.jpeg Science https://www.genervon.com/cns-indications daily 0.75 2023-06-13 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619241469039-1HCMTVGYDXDF2JI95URP/GM6+ALS+2.png CNS Indications https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619238540168-TVQJO1PR9HCWINXE1HMY/GM6+PD+2.png CNS Indications https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619307704008-V7Z8CW2ZTC2RDJ9L39OG/GM6+stroke+2.png CNS Indications Treatment with GM6 reduced infarct size in a dose-dependent manner with statistical significance. https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619307743127-QNEOORQQNQI73KLHUHWS/GM6+stroke+4.png CNS Indications Treatment with GM6 improved motor function as seen in the statistically significant reduction in neurological deficit scores in a dose-dependent manner. https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619307661834-8PO4O67TDDGAQD8Y4M79/GM6+stroke+1.png CNS Indications 1 hour occlusion of middle cerebral artery (MCAO) of mice, drug given IV at beginning of 24-hour reperfusion https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619307721694-YG1QMCO42ASP2XKBDZ6P/GM6+stroke+3.png CNS Indications Neurological scores were as follows: 0, normal motor function; 1, flexion of torso and contralateral forelimb when animal was lifted by the tail; 2, circling to the contralateral side when held by tail on flat surface, but normal posture at rest; 3, leaning to the contralateral side at rest; 4, no spontaneous motor activity. https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619323147630-YG87V547LT7NRZIQP63X/MS+2.png CNS Indications https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619323018480-74R0I5RI2OGUKPUZCBOX/MS+1.png CNS Indications https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619311372223-YZ71H3A819EISLDBF9CT/Spinal+Cord+Injury+1.png CNS Indications A. Vehicle treated mouse. B. Mouse treated with 5 mg/kgGM6. https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619311520992-HZVB55QK8YLZ5HWO7P2V/Spinal+Cord+Injury+2.png CNS Indications https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619311540408-7JSMOVJPBI0AUCIK2PFA/Spinal+Cord+Injury+3.png CNS Indications https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619214809361-N3IOWWV20JDMBJ3C17GT/AdobeStock_18133113.jpeg CNS Indications https://www.genervon.com/overview daily 0.75 2021-04-24 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1508631344993-VT98XUPG69L4FIQ1FYIU/AdobeStock_141025938.jpeg Overview https://www.genervon.com/contact daily 0.75 2023-09-22 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1508740606116-1CQ7RY69IJ6X290T4EB9/AdobeStock_116876188.jpeg Contact https://www.genervon.com/summary-of-gm604 daily 0.75 2017-10-23 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1508713767612-POWP3RV7K1Z10OM40WON/Patient111Diagram.jpg Summary of GM604 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1508713784265-ETIFOHW1YJYKLCSJC4FE/Patient112Diagram.jpg Summary of GM604 https://www.genervon.com/gm604-reduced-tdp43 daily 0.75 2017-10-22 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1508714099168-L0C3GS42TLBWYOGBHQWV/G-Picture+B.jpg GM604 Reduced TDP-43 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1508714147353-NKFWBOD1B87D1FD9BPCB/F-Picture.jpg GM604 Reduced TDP-43 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1508714124673-WXLQBQULKBKXD90Z015U/A-Picture.jpg GM604 Reduced TDP-43 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1508714072092-SPWZGAFHDOT66ZSKXH88/G-Picture+A.jpg GM604 Reduced TDP-43 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1508714027809-8FKAREITU4KVRBH7ZVQZ/Dr.Wong+Fig.+4.jpg GM604 Reduced TDP-43 https://www.genervon.com/trial-data-old daily 0.75 2017-12-08 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1508526802659-2N3F3WUJHAANF4BMBT4W/AdobeStock_18133113.jpeg Trial Data (Old) https://www.genervon.com/pipeline-1 daily 0.75 2021-04-23 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619211532611-UI7LRIPPZZJ2BBLIVIIO/pipeline+chart+-+large.png Pipeline https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1508526655639-W5J4NZFTBSE1J41AGTQ7/AdobeStock_18133113.jpeg Pipeline https://www.genervon.com/ourteam daily 0.75 2021-04-11 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1508477252975-2D1DZ8ECS6TNKALSNC15/AdobeStock_96935929.jpeg Our Team https://www.genervon.com/innovation daily 0.75 2021-04-23 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1508526608365-FLEXM88G2GUIR1NW0K3A/AdobeStock_18133113.jpeg Innovation + Patents https://www.genervon.com/clinical-trials daily 0.75 2021-04-22 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1508526757660-MSU96XC6QIH5WULCS55N/AdobeStock_18133113.jpeg Clinical Trials https://www.genervon.com/safety-and-efficacy daily 0.75 2018-09-20 https://www.genervon.com/c9orf72 daily 0.75 2017-10-23 https://www.genervon.com/safety-and-efficacy-for-gm daily 0.75 2018-09-20 https://www.genervon.com/media daily 0.75 2021-04-23 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1515303537369-J850VHJ4N80PKZJIBIIW/AdobeStock_112508174.jpeg Media https://www.genervon.com/gm6-als-moa-diagram daily 0.75 2019-12-05 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1575577087837-ZDXGM5LGDXFSG9PI3AM0/ALS+MOA.png GM6 ALS MOA Diagram https://www.genervon.com/mechanisms-of-action daily 0.75 2021-04-22 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1508526655639-W5J4NZFTBSE1J41AGTQ7/AdobeStock_18133113.jpeg Mechanisms of Actions https://www.genervon.com/ad-animal-model-data daily 0.75 2021-04-22 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1537831024916-LLZCB1HPCGH6GNDSHIRM/Poster-GM6+attenuates+AD+in+APP+Mice.20180925.web.jpg Alzheimer's Disease Animal Model Data https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1618099721357-B8U2GV64I9E2CFD6X2R3/Poster+1-GM6+can+block+tau+hyperphosphorylation+induced+by+AGEs+and+A%CE%B2%400.75x.png Alzheimer's Disease Animal Model Data https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1618099695602-60JFHF8X64WSRAJYLPFC/Poster+2-+GM6+effect+in+h-Tau+mice%400.75x.png Alzheimer's Disease Animal Model Data https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1508526655639-W5J4NZFTBSE1J41AGTQ7/AdobeStock_18133113.jpeg Alzheimer's Disease Animal Model Data https://www.genervon.com/gm6-ad-moa daily 0.75 2018-09-24 https://www.genervon.com/gm6-als-moa daily 0.75 2018-09-24 https://www.genervon.com/gm6-ad-moa-diagram daily 0.75 2019-12-05 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1575577158903-SF9VMLN1FLOAOYV8JMVX/AD+MOA.png GM6 AD MOA Diagram https://www.genervon.com/wuxi-ceo-roundtable-2019-ch daily 0.75 2019-03-02 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1551470674924-3QY6NYQ9GSN0CS9MZP2P/WuXi+Presentation+Chinese_Page_6.png WuXi CEO Roundtable 2019 Chinese https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1551470656453-UJSZUTIJUNGW0HGMAOTY/WuXi+Presentation+Chinese_Page_5.png WuXi CEO Roundtable 2019 Chinese https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1551468558636-C90IG2U9I181NROP8K2V/WuXi+Presentation+Chinese_Page_1.png WuXi CEO Roundtable 2019 Chinese https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1551468630599-SRRCDPCEC0BZIN53X40F/WuXi+Presentation+Chinese_Page_4.png WuXi CEO Roundtable 2019 Chinese https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1551468610761-VS73WL8MW1WUV2OEG5KM/WuXi+Presentation+Chinese_Page_3.png WuXi CEO Roundtable 2019 Chinese https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1551468580701-6PUMZI147UPL10QYGLWS/WuXi+Presentation+Chinese_Page_2.png WuXi CEO Roundtable 2019 Chinese https://www.genervon.com/news-wuxi-ceo-roundtable-2019 daily 0.75 2019-03-03 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1551469554484-VQX16O9G9Q7U22K9IGMG/WuXiImage.png News - WuXi CEO Roundtable 2019 https://www.genervon.com/wuxi-ceo-roundtable-2019-en daily 0.75 2019-03-02 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1551467357060-GIXBWGCPRDU5V6V71W1J/Genervon+Company+Overview+February+2019+v3+%28w+Video+link+%26+video%29+-+for+web_Page_1.png WuXi CEO Roundtable 2019 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1551467381597-7K5YS3TRE54JWRGOICN5/Genervon+Company+Overview+February+2019+v3+%28w+Video+link+%26+video%29+-+for+web_Page_2.png WuXi CEO Roundtable 2019 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1551470618342-EHDVXPZHUPEQ6J8DNOGN/Genervon+Company+Overview+February+2019+v3+%28w+Video+link+%26+video%29+-+for+web_Page_6.png WuXi CEO Roundtable 2019 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1551467423993-YP8O9S8W5NBW3E18CIXF/Genervon+Company+Overview+February+2019+v3+%28w+Video+link+%26+video%29+-+for+web_Page_4.png WuXi CEO Roundtable 2019 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1551467404002-22Y4HP3B2MLU48ZTTOJ0/Genervon+Company+Overview+February+2019+v3+%28w+Video+link+%26+video%29+-+for+web_Page_3.png WuXi CEO Roundtable 2019 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1551470601878-7Q4WPCRQ7QGZLSP3BBHU/Genervon+Company+Overview+February+2019+v3+%28w+Video+link+%26+video%29+-+for+web_Page_5.png WuXi CEO Roundtable 2019 https://www.genervon.com/news-2018-alsmnd-symposium daily 0.75 2019-03-03 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1551649058005-WZVJUEB38474LE9S30N9/ALS+poster+-+20181208+ALS+Symposium+w+link.png News - 2018 ALS/MND Symposium https://www.genervon.com/news-gm6-attenuates-alzheimers-disease-pathology-in-app-mice daily 0.75 2019-03-03 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1551557914717-VVYKPSRUBNVDT1534CA0/ASENT+logo+main.png News - ASENT 2019 https://www.genervon.com/whats-new daily 0.75 2023-06-13 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1515303537369-J850VHJ4N80PKZJIBIIW/AdobeStock_112508174.jpeg What's New https://www.genervon.com/news-wuxi-ceo-roundtable-2019-1 daily 0.75 2019-03-03 https://www.genervon.com/gm6-pd-moa-diagram daily 0.75 2021-04-21 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619042811926-8N56AT6DYMFQPXQOOMZ3/PD+MOA.png GM6 PD MOA Diagram https://www.genervon.com/in-vivo-poster daily 0.75 2020-03-04 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1583302095232-3CZQGTGKPXZD9BCG7X7T/in+vivo+poster.png in vivo Poster https://www.genervon.com/in-vitro-poster daily 0.75 2020-03-04 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1583299551484-N2HXN9B58YW3N0JYNSCP/in+vitro+poster.png In Vitro Poster https://www.genervon.com/poster-1gm6-can-block-tau-hyperphosphorylation-induced-by-ages-and-a daily 0.75 2021-04-11 https://www.genervon.com/trial-data daily 0.75 2021-04-22 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619041167929-ML660592A810DYWPXAUW/Safety+and+Efficacy+Summary+for+GM6-2-sq.jpg Trial Data https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619040164401-7QXIJE2873T4JZROXNAB/2017-12-06+GM604+ALS+poster-sq.jpg Trial Data https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619040225715-F2IHNL3KVE2NLGGJ1PAN/A+Phase+2A+randomized%2C+double-blind%2C...+%7C+F1000Research-1-sq.jpg Trial Data https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1508526802659-2N3F3WUJHAANF4BMBT4W/AdobeStock_18133113.jpeg Trial Data https://www.genervon.com/gm6 daily 0.75 2021-04-23 https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619064397405-R7DEZDCQY7JIN8NEIGDK/MNTF+neurotrophin.png GM6 Overview https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619120752564-NUSPFR1RZUZGU4JV4VAN/GM6+stroke+1.png GM6 Overview https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619120782794-HOCV982PK6ZILJC6BE2Z/GM6+stroke+3.png GM6 Overview https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619064414480-NH44ZPY4P4AK60KG9QT7/MNTF+expression.png GM6 Overview This chart shows the change in MNTF expression in human placenta over the course of gestation in weeks. MNTF expression rose rapidly during the 6th to 9th weeks of gestation in placenta with increasing week-age, peaked at the 9th week, and then declined progressively. https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619065830330-IXX1Q733GNWJD242BTIK/GM6+BBB.png GM6 Overview https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619070014274-VQAV6MTQ7XT1R8PB5YWC/GM6+PD+2.png GM6 Overview https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619209083281-IKAUUMX0Z68AVXYXQ2K3/GM6+neuroprotection+2.png GM6 Overview https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619064609258-ILZHI60GT8RBKI09FI2T/GM6+development.jpg GM6 Overview https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619120942108-MY2QTJVOJEQD498Q1A6V/GM6+stroke+4.png GM6 Overview https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619120769018-15HFXN7J3T2MUTSJ24KQ/GM6+stroke+2.png GM6 Overview https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1619069321073-YPIDSM3S5OWLT7OW90ZX/GM6+ALS+2.png GM6 Overview https://images.squarespace-cdn.com/content/v1/59e8ea02f6576ee55602b034/1508526802659-2N3F3WUJHAANF4BMBT4W/AdobeStock_18133113.jpeg GM6 Overview https://www.genervon.com/read-me daily 0.75 2025-05-12 https://images.squarespace-cdn.com/content/v1/5310cef7e4b08602cbfa36bf/1412689652885-P9TPK298WCTZU748L0SG/Lifestyle03.jpg Read Me